Device Trial Radar · NCT06093815
Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products
Last checked: Nov 20, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Sep 8, 2023
Primary completion
May 1, 2024
Study completion Nov 1, 2024
Sponsor
- Lead sponsor
- Merz North America, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 23, 2023
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to identify and assess in vivo tissue responses after injection with various biostimulatory products at various timepoints. The study will also provide tissue specimens which will be used in a subsequent study. Safety endpoint: incidence of adverse events.
Conditions
- Injection Site Reaction
Interventions
InjectionDevice
A pre specified amount will be injected in tissue at selected timepoints
Primary outcomes
What the sponsor says the trial is designed to measure.
- Arm 1 - Ultrasound Analyses - Skin Thickness (mm)Time frame: 6 months, 3 months and 2 weeks prior to surgery timepoint(s)
- Arm 1 - Ultrasound Analyses - ElastosisTime frame: 6 months, 3 months and 2 weeks prior to surgery timepoint(s)
- Arm 1 - Ultrasound Analyses - Microvascular FormationTime frame: 6 months, 3 months and 2 weeks prior to surgery timepoint(s)
3 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ocean Clinic - Av. Ramon y Cajal 7, 29601
Marbella, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.